Drug‐induced liver injury at an Asian center: a prospective study
- 14 March 2007
- journal article
- Published by Wiley in Liver International
- Vol. 27 (4), 465-474
- https://doi.org/10.1111/j.1478-3231.2007.01461.x
Abstract
Background/Aims: The aetiology of drug-induced liver injuries (DILI) in Asia is different from that in the West, as anecdotal studies have shown that traditional complementary and alternative medicines (CAM) accounted for a major proportion of offending drugs in DILI in Asia. We aimed to study DILI in Asia prospectively, and to test whether DILI caused by traditional CAM was related to adulterants. Methods: A collaborative group consisting of a tertiary-hospital hepatology department, a pharmaceutical laboratory, and a pharmacovigilance unit was formed to study patients with DILI at a tertiary hospital over a 26-month period prospectively. Traditional medicines that were implicated were tested for the presence of adulterants. Results: Thirty-one patients with DILI were enrolled: age 51±3 (18–79) years, 17 (55%) male. Twenty-three (74%) had hepatocellular, six (19%) had cholestatic, and two (7%) had a mixed pattern of injury. Chinese traditional CAM was the most common medication type implicated, accounting for 17 (55%) patients, followed by Malay CAM in five (16%). Thirty-one traditional medicines from 17 patients were available for chemical analysis. Adulterants were found in nine (29%) of them. Conclusions: DILI in Asia has a different aetiology as compared with the West, and could be related to presence of adulterants in traditional CAM.Keywords
This publication has 23 references indexed in Scilit:
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year PeriodGastroenterology, 2005
- Autoantibodies Against CYP2D6 and Other Drug-Metabolizing Enzymes in Autoimmune Hepatitis Type 2Drug Metabolism Reviews, 2005
- Pharmacists' Patterns of Use, Knowledge, and Attitudes Toward Complementary and Alternative MedicineThe Journal of Alternative and Complementary Medicine, 2003
- Incidence of drug-induced hepatic injuries: A French population-based studyJournal of Hepatology, 2002
- Efficacy, safety, and tolerability in patients switched to PEG (40 kDa) IFN α-2a (PEGASYS®) after discontinuation from interferon alfa-2b plus ribavirin (REBETRON™) combination therapy for chronic hepatitis CGastroenterology, 2001
- Development and validation of a clinical scale for the diagnosis of drug-induced hepatitisJournal of Hepatology, 1997
- Adulteration by Synthetic Therapeutic Substances of Traditional Chinese Medicines in TaiwanThe Journal of Clinical Pharmacology, 1997
- Criteria of drug-induced liver disorders: Report of an International Consensus MeetingJournal of Hepatology, 1990
- Antibody mediated hepatocyte injury in methyl dopa induced hepatotoxicity.Gut, 1985
- Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodiesJournal of Hepatology, 1985